$CHE

CHEMED CORP

CIK:0000019584|SEC Filings

Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Consolidated Statements Of Income [Abstract]
Service revenues and sales	$ 673,251	$ 618,798	$ 1,330,764	$ 1,265,741
Cost of services provided and goods sold (excluding depreciation)	451,780	434,105	893,529	864,635
Selling, general and administrative expenses	115,203	100,323	229,524	205,910
Depreciation	14,267	13,689	28,570	27,134
Amortization	2,719	2,571	5,289	5,143
Other operating expense	78	26	70	77
Total costs and expenses	584,047	550,714	1,156,982	1,102,899
Income from operations	89,204	68,084	173,782	162,842
Interest expense	(1,789)	(443)	(2,301)	(772)
Other income - net	3,914	3,474	8,688	4,719
Income before income taxes	91,329	71,115	180,169	166,789
Income taxes	(23,626)	(18,622)	(46,164)	(42,539)
Net income	$ 67,703	$ 52,493	$ 134,005	$ 124,250
Earnings Per Share:
Net income	$ 5.14	$ 3.60	$ 9.98	$ 8.51
Average number of shares outstanding	13,174	14,591	13,423	14,606
Diluted Earnings Per Share:
Net income	$ 5.13	$ 3.57	$ 9.97	$ 8.43
Average number of shares outstanding	13,199	14,703	13,442	14,733
Cash Dividends Per Share	$ 0.60	$ 0.50	$ 1.20	$ 1.00

Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows from Operating Activities
Net income	$ 134,005	$ 124,250
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	33,859	32,277
Stock option expense	18,302	18,307
Benefit for deferred income taxes	(4,262)	(13,243)
Noncash long-term incentive compensation	3,633	3,273
Noncash directors' compensation	1,191	1,123
Litigation settlements	548
Amortization of debt issuance costs	163	160
Changes in operating assets and liabilities:
Increase in accounts receivable	(6,716)	(13,466)
Increase in inventories	(87)	(955)
Increase in prepaid expenses	(10,285)	(7,232)
Increase/(decrease) in accounts payable and other current liabilities	9,174	(12,449)
Change in current income taxes	(8,985)	(10,764)
Net change in lease assets and liabilities	292	(72)
(Increase)/decrease in other assets	(9,489)	48,426
Increase in other liabilities	11,191	1,521
Other sources	498	194
Net cash provided by operating activities	173,032	171,350
Cash Flows from Investing Activities
Business combinations, net of cash acquired	(33,540)	(225)
Capital expenditures	(32,639)	(29,088)
Proceeds from sale of fixed assets	422	480
Other uses	(270)	(322)
Net cash used by investing activities	(66,027)	(29,155)
Cash Flows from Financing Activities
Proceeds from revolving line of credit	491,480
Payments on revolving line of credit	(351,480)
Purchases of treasury stock	(287,521)	(76,168)
Change in cash overdrafts payable	23,305	309
Dividends paid	(16,049)	(14,542)
Proceeds from exercise of stock options	2,731	27,152
Capital stock surrendered to pay taxes on stock-based compensation	(1,482)	(8,484)
Debt issuance costs	(1,349)
Other (uses)/sources	(933)	1,092
Net cash used by financing activities	(141,298)	(70,641)
(Decrease)/increase in Cash and Cash Equivalents	(34,293)	71,554
Cash and cash equivalents at beginning of period	74,515	178,350
Cash and cash equivalents at end of period	$ 40,222	$ 249,904

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 40,222	$ 74,515
Accounts receivable less allowances	188,634	182,575
Inventories	7,630	7,543
Prepaid income taxes	17,646	11,165
Prepaid expenses	37,103	26,818
Total current assets	291,235	302,616
Investments of deferred compensation plans held in trust	148,153	140,347
Properties and equipment, at cost, less accumulated depreciation of $403,739 (2025- $388,104)	208,499	205,662
Lease right of use asset	142,535	131,151
Identifiable intangible assets less accumulated amortization of $74,720 (2025 - $69,432)	78,601	82,764
Goodwill	699,398	666,999
Other assets	11,164	8,650
Total Assets	1,579,585	1,538,189
Current liabilities
Accounts payable	84,713	64,459
Accrued insurance	72,455	62,054
Accrued compensation	63,794	58,329
Short-term lease liability	41,277	40,892
Income taxes		2,504
Other current liabilities	57,607	58,892
Total current liabilities	319,846	287,130
Deferred compensation liabilities	146,986	136,139
Long-term debt	140,000
Long-term lease liability	113,516	102,867
Deferred income taxes	15,050	19,313
Other liabilities	13,677	13,335
Total Liabilities	749,075	558,784
Commitments and contingencies (Note 10)
STOCKHOLDERS' EQUITY
Capital stock - authorized 80,000,000 shares $1 par; issued 37,612,657 shares (2025 - 37,594,676 shares)	37,613	37,595
Paid-in capital	1,617,125	1,592,197
Retained earnings	3,073,331	2,955,375
Treasury stock - 24,597,558 shares (2025 - 23,884,187 shares)	(3,900,000)	(3,608,117)
Deferred compensation payable in Company stock	2,441	2,355
Total Stockholders' Equity	830,510	979,405
Total Liabilities and Stockholders' Equity	$ 1,579,585	$ 1,538,189